Introduction to laser thermal therapy for brain disorders.
Introduction to laser thermal therapy for brain disorders.
复制标题
DOI:
10.1080/02656736.2020.1789764
复制
发表时间:
2020-07
期刊:
影响因子:
--
通讯作者:
Mohammadi AM
中科院分区:
文献类型:
--
作者:
Yu JS;Mohammadi AM
Hyperthermia has long been recognized in medicine for its therapeutic properties. While hyperthermia has become widely used extracranially for many years, its use in the brain has been hampered by technical and safety concerns. A phase-III clinical trial with microwave hyperthermia led to prolongation of survival in patients with glioblastoma, a lethal primary brain tumor [1]. Yet, technical challenges in microwave interstitial catheter implantation, limitations in thermometry, quality and safety concerns, and lack of programs to train physicians and surgeons in this technique led to its abandonment. Unfortunately, the early success with brain hyperthermia was cast aside. Mainstream medicine moved on to new chemotherapies, targeted agents and immunotherapy.The last few years have ushered a resurgence of hyperthermia applications in the brain. Advances in laser, ultrasound and MRI technologies have improved the delivery and quality of hyperthermia. Stereotactic mapping of targets coupled with real-time thermometry has enabled safe delivery of hyperthermia. These advances have renewed interest in hyperthermia in the management of brain tumors. Additionally, indications have expanded to include treatment of radiation necrosis, a complication of radiosurgery commonly used to treat brain metastases, and functional disorders including epilepsy. Due to its minimally invasive technique, brain hyperthermia, particularly laser ablation, offers an appealing alternative to traditional craniotomy. With reduced recovery time and length of hospitalization, patients may go on to radiation therapy or systemic treatment more quickly. The clinical and economic value of brain hyperthermia is increasingly being realized.
登录
查看更多内容
影响因子:
11.2
作者:
Man J;Shoemake JD;Ma T;Rizzo AE;Godley AR;Wu Q;Mohammadi AM;Bao S;Rich JN;Yu JS
通讯作者:
Yu JS
影响因子:
17.1
作者:
Atkinson RL;Zhang M;Diagaradjane P;Peddibhotla S;Contreras A;Hilsenbeck SG;Woodward WA;Krishnan S;Chang JC;Rosen JM
通讯作者:
Rosen JM
DOI:
10.1080/02656736.2020.1783461
发表时间:
2020-07
期刊:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
影响因子:
--
作者:
Patel B;Yang PH;Kim AH
通讯作者:
Kim AH
影响因子:
3.1
作者:
Srinivasan, Ethan S.;Sankey, Eric W.;Fecci, Peter E.
通讯作者:
Fecci, Peter E.
DOI:
10.1080/02656736.2020.1772512
发表时间:
2020-07
期刊:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
影响因子:
--
作者:
Skandalakis GP;Rivera DR;Rizea CD;Bouras A;Jesu Raj JG;Bozec D;Hadjipanayis CG
通讯作者:
Hadjipanayis CG